• By ICR Secretariat
  • Posted Tuesday, June 25, 2019

Merck is on top. Investors worry there's only one way to go.

https://www.biopharmadive.com/news/merck-investor-day-drugs-keytruda-pricing-deals-ceo/557295/

NEW YORK — Merck & Co.'s investor day suggested it is a company on top.

Stage lights turned the tall, white walls of 583 Park Avenue a blueish green, reminiscent of the drugmaker's logo. Rows of gold-painted chairs seated well-known Wall Street types. A large, crystaline chandelier dangled underneath a domed ceiling